Keith Sullivan

Keith Sullivan

Duke University

H-index: 128

North America-United States

About Keith Sullivan

Keith Sullivan, With an exceptional h-index of 128 and a recent h-index of 44 (since 2020), a distinguished researcher at Duke University, specializes in the field of hematopoietic stem cell transplantation, graft vs host disease, sickle cell disease, scleroderma.

His recent articles reflect a diverse array of research interests and contributions to the field:

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis

REPRINTED WITH PERMISSION OF IASP–PAIN 164 (2023) 741–748: Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 …

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation

Clinical and molecular findings after autologous stem cell transplantation or cyclophosphamide for scleroderma: handling missing longitudinal data

Rekombinowana adjuwantowa szczepionka przeciwko półpaścowi zmniejsza ból związany z półpaścem oraz redukuje stosowanie leków przeciwbólowych w trzech randomizowanych …

PRZEDRUK POLSKIEGO TŁUMACZENIA ARTYKUŁU ZA ZGODĄ INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN (IASP)–PAIN 164 (2023) 741–748: Rekombinowana adjuwantowa szczepionka przeciwko …

Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions

Enrollment lessons from a biological assignment study of marrow transplantation versus standard care for adolescents and young adults with sickle cell disease: considerations …

Keith Sullivan Information

University

Position

Professor of Medicine

Citations(all)

57966

Citations(since 2020)

8191

Cited By

53398

hIndex(all)

128

hIndex(since 2020)

44

i10Index(all)

391

i10Index(since 2020)

148

Email

University Profile Page

Duke University

Google Scholar

View Google Scholar Profile

Keith Sullivan Skills & Research Interests

hematopoietic stem cell transplantation

graft vs host disease

sickle cell disease

scleroderma

Top articles of Keith Sullivan

Title

Journal

Author(s)

Publication Date

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis

Annals of the rheumatic diseases

Julia Z Adamska

Amin Zia

Michelle S Bloom

Leslie J Crofford

Daniel E Furst

...

2023/3/1

REPRINTED WITH PERMISSION OF IASP–PAIN 164 (2023) 741–748: Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 …

Ból

Joon Hyung Kim

Robert Johnson

Martina Kovac

Anthony L Cunningham

Mohamed Amakrane

...

2023/7/27

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation

Annals of the Rheumatic Diseases

Burcu Ayoglu

Michele Donato

Daniel E Furst

Leslie J Crofford

Ellen Goldmuntz

...

2023/5/1

Clinical and molecular findings after autologous stem cell transplantation or cyclophosphamide for scleroderma: handling missing longitudinal data

Arthritis Care & Research

Lynette Keyes‐Elstein

Ashley Pinckney

Ellen Goldmuntz

Beverly Welch

Jennifer M Franks

...

2023/2

Rekombinowana adjuwantowa szczepionka przeciwko półpaścowi zmniejsza ból związany z półpaścem oraz redukuje stosowanie leków przeciwbólowych w trzech randomizowanych …

Pain Research/Ból

Joon Hyung Kim

Robert Johnson

Martina Kovac

Anthony L Cunningham

Mohamed Amakrane

...

2023/4/1

PRZEDRUK POLSKIEGO TŁUMACZENIA ARTYKUŁU ZA ZGODĄ INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN (IASP)–PAIN 164 (2023) 741–748: Rekombinowana adjuwantowa szczepionka przeciwko …

Ból

Ashley F Curtis

Mary Beth Miller

Himangshu Rathlnakumar

Michael Robinson

Roland Staud

...

2020/7/27

Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions

Keith M Sullivan

Francis A Farraye

Kevin L Winthrop

David O Willer

Peter Vink

...

2023/1/4

Enrollment lessons from a biological assignment study of marrow transplantation versus standard care for adolescents and young adults with sickle cell disease: considerations …

Transplantation and Cellular Therapy

Lakshmanan Krishnamurti

Donna Neuberg

Keith M Sullivan

Shannon Smith

Mary Eapen

...

2023/4/1

Caring for Our Patients, Their Loved Ones and Each Other

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Keith M Sullivan

2023/7/1

Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials

Pain

Joon Hyung Kim

Robert Johnson

Martina Kovac

Anthony L Cunningham

Mohamed Amakrane

...

2023/4/1

Reflections: A New Monthly Feature in Transplantation and Cellular Therapy

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Keith M Sullivan

Stephen J Forman

Robert Korngold

David L Porter

2023/7/1

Stem cell transplantation in autoimmune diseases (AID)

Frontiers in Immunology

Marc Schmalzing

Joerg Henes

Jacob M van Laar

Keith M Sullivan

2023/3/1

Improving outcomes in scleroderma: recent progress of cell-based therapies

Dinesh Khanna

Nancy Krieger

Keith M Sullivan

2023/6/1

AB1072 HERPES ZOSTER IN INDIVIDUALS WITH AUTOIMMUNE DISEASES AND RECOMBINANT HERPES ZOSTER VACCINE AS A PREVENTATIVE STRATEGY

K Winthrop

FA Farraye

KM Sullivan

DO Willer

P Vink

...

2022/6/1

EPR22-118: Incidence of Herpes Zoster in Immunocompromised Individuals and Zoster Vaccination as an Effective Preventative Strategy

Journal of the National Comprehensive Cancer Network

Keith M Sullivan

Kevin L Winthrop

David O Willer

Peter Vink

Fernanda Tavares Da Silva

2022/3/31

Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy

Rheumatology

Ankoor Shah

Jan Storek

Rob Woolson

Ashley Pinckney

Lynnette Keyes-Elstein

...

2022/10/1

Myeloablation followed by hematopoietic stem cell transplantation leads to long‐term normalization of systemic sclerosis molecular signatures

Arthritis & Rheumatology

Nancy Wareing

Xuan Wang

Lynette Keyes‐Elstein

Ellen A Goldmuntz

Marka A Lyons

...

2022/9/1

Quantifying skin stiffness in graft-versus-host disease, morphea, and systemic sclerosis using acoustic radiation force impulse imaging and shear wave elastography

The Journal of investigative dermatology

Adela R Cardones

Russell P Hall 3rd

Keith M Sullivan

Joanna Hooten

Seung Yun Lee

...

2021/4

Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation

Bone marrow transplantation

Ko K Maung

Benny J Chen

Ian Barak

Zhiguo Li

David A Rizzieri

...

2021/1

Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

Human vaccines & immunotherapeutics

Edward A Stadtmauer

Keith M Sullivan

Mohamed El Idrissi

Bruno Salaun

Aránzazu Alonso Alonso

...

2021/11/2

See List of Professors in Keith Sullivan University(Duke University)

Co-Authors

H-index: 59
Lawrence G. Lum

Lawrence G. Lum

University of Virginia

H-index: 59
Nancy Flournoy

Nancy Flournoy

University of Missouri

H-index: 26
Anthony D Sung

Anthony D Sung

Duke University

academic-engine